Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS ELIZABETH

  • FDA Approval
  • Jan. 08, 2025, 09:45 UTC
  • 39

FDA approve GABAPENTIN

Comment Full text

CIPLA

  • FDA Approval
  • Jan. 07, 2025, 09:52 UTC
  • 37

FDA approve PHYTONADIONE

Comment Full text

SCINOPHARM TAIWAN

  • FDA Approval
  • Jan. 07, 2025, 09:52 UTC
  • 33

FDA approve CLOFARABINE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • Jan. 07, 2025, 09:52 UTC
  • 34

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

ADAPTIS

  • FDA Approval
  • Jan. 07, 2025, 09:52 UTC
  • 39

FDA approve BICALUTAMIDE

Comment Full text

ALKEM

  • FDA Approval
  • Jan. 07, 2025, 09:52 UTC
  • 40

FDA approve AMLODIPINE BESYLATE

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • Jan. 06, 2025, 09:45 UTC
  • 40

FDA approve LUBIPROSTONE

Comment Full text

APOTEX

  • FDA Approval
  • Jan. 06, 2025, 09:45 UTC
  • 40

FDA approve MIRABEGRON

Comment Full text

AGIOS PHARMS INC

  • FDA Approval
  • Jan. 03, 2025, 20:19 UTC
  • 41

FDA approve MITAPIVAT SULFATE

Comment Full text

AM REGENT

  • FDA Approval
  • Jan. 03, 2025, 20:19 UTC
  • 35

FDA approve FERRIC CARBOXYMALTOSE

Comment Full text
  • Previous
  • 164
  • 165
  • 166
  • 167
  • 168
  • Next

Search

News categories

  • Technical Exchange News(9869)
  • Event(407)
  • SEC News(167081)
  • FDA Approval(9320)
  • Company Report(721)
  • Business News(110962)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin